Development Level

Tbio 3 | 10,625
Tdark 2 | 7,003
Tclin 1 | 602

IMPC Term

abnormal bone structure 1 | 131

Disease

ductal carcinoma in situ 4 | 1,745
invasive ductal carcinoma 4 | 2,950
psoriasis 4 | 6,685
Atherosclerosis 3 | 275
Cancer 3 | 2,346
Cerebrovascular disease 3 | 231
Coronary artery disease 3 | 240
Diabetes Mellitus, Non-Insulin-Dependent 3 | 157
Fatty liver disease 3 | 84
Heart disease 3 | 279
Heart failure 3 | 80
Hepatitis C 3 | 90
Hyperglycemia 3 | 120
Hyperinsulinism 3 | 63
Hypertension 3 | 287
Hypertensive disease 3 | 193
Insulin Resistance 3 | 48
Kidney disease 3 | 396
Lipid metabolism disorder 3 | 102
Lipodystrophy 3 | 32
Liver disease 3 | 219
Metabolic syndrome X 3 | 155
Obesity 3 | 616
Obstructive sleep apnea 3 | 28
Osteoporosis 3 | 257
Polycystic Ovary Syndrome 3 | 332
diabetes mellitus 3 | 1,663
interstitial cystitis 3 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
Acute kidney injury 2 | 65
Albuminuria 2 | 20
Allergic hypersensitivity disease 2 | 123
Alzheimer's disease 2 | 644
Anemia 2 | 252
Arthritis 2 | 248
Arthritis, Experimental 2 | 39
Atopic dermatitis 2 | 944
Bipolar Disorder 2 | 266
Brain disease 2 | 83
Cardiac arrest 2 | 26
Coronary Restenosis 2 | 8
Crohn Disease 2 | 97
Dementia 2 | 129
Diabetes Mellitus, Insulin-Dependent 2 | 76
Diabetic Cardiomyopathies 2 | 10
Diabetic Nephropathy 2 | 37
Diabetic Retinopathy 2 | 53
Diarrhea 2 | 155
Drug-Induced Liver Injury 2 | 118
Edema 2 | 38
Fatty Liver 2 | 48
Hyperandrogenism 2 | 32
Hypersensitivity reaction type II disease 2 | 235
Hypoglycemia 2 | 81
Hypotension 2 | 53
Infertility 2 | 163
Inflammation 2 | 109
Kidney Failure, Chronic 2 | 45
Liver Cirrhosis, Experimental 2 | 108
Liver Failure, Acute 2 | 22
Lung disease 2 | 132
Myocardial Ischemia 2 | 169
Myopathy 2 | 128
Neuropathy 2 | 210
Pancreatitis 2 | 97
Parkinson Disease 2 | 102
Rheumatoid Arthritis 2 | 1,160
Schizophrenia 2 | 501
Tachycardia 2 | 17
Weight Gain 2 | 87
Weight decreased 2 | 18
adrenocortical carcinoma 2 | 1,427
cystic fibrosis 2 | 1,665
dermatomyositis 2 | 933
fibroadenoma 2 | 557
non-small cell lung cancer 2 | 2,798
pilocytic astrocytoma 2 | 3,086
ADULT syndrome 1 | 9
ASTHMA, SUSCEPTIBILITY TO (finding) 1 | 6
Acanthosis nigricans 1 | 14
Acute coronary syndrome 1 | 37
Berylliosis 1 | 16
Cystitis 1 | 16
Diaphragmatic Hernia 1 | 40
Fanconi Anemia 1 | 19
Hemophagocytic lymphohistiocytosis 1 | 30
Hyperprolactinemia 1 | 22
Leishmaniasis, Visceral 1 | 13
MALARIA, CEREBRAL, SUSCEPTIBILITY TO (finding) 1 | 3
Memory Disorders 1 | 36
Neurogenic Inflammation 1 | 12
Oral Submucous Fibrosis 1 | 18
Plaque psoriasis 1 | 14
Prostatitis 1 | 15
Psoriasis with arthropathy 1 | 11
Retinal Diseases 1 | 21
Takayasu's arteritis 1 | 52
hemolytic-uremic syndrome 1 | 28

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444
Respiratory system 5 | 17,484

Target Family

Non-IDG 6 | 11,971

Grant Application

1F32DK067835-01 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Complement C1q tumor necrosis factor-related protein 7 C1QTNF7 Tdark Non-IDG -0.14212 1.27 166
Complement C1q tumor necrosis factor-related protein 1 C1QTNF1 Tbio Non-IDG -0.98310 18.3 173
Complement C1q tumor necrosis factor-related protein 2 C1QTNF2 Tdark Non-IDG -0.12740 2.10 186
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
Adiponectin ADIPOQ Tbio Non-IDG -3.79934 7127.0 1100